3-[2-(3-aminopropoxy)-3,5-dibromophenyl]-N-[2-(4-chlorophenyl)ethyl]-2-hydroxyiminopropanamide hydrochloride

ID: ALA538576

Max Phase: Preclinical

Molecular Formula: C20H23Br2Cl2N3O3

Molecular Weight: 547.68

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.NCCCOc1c(Br)cc(Br)cc1C/C(=N/O)C(=O)NCCc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C20H22Br2ClN3O3.ClH/c21-15-10-14(19(17(22)12-15)29-9-1-7-24)11-18(26-28)20(27)25-8-6-13-2-4-16(23)5-3-13;/h2-5,10,12,28H,1,6-9,11,24H2,(H,25,27);1H/b26-18-;

Standard InChI Key:  IGJVTLFRLSJUNT-ZVOSEVRTSA-N

Molfile:  

     RDKit          2D

 30 30  0  0  0  0  0  0  0  0999 V2000
    5.0987   -2.2494    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0031   -3.0008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3039   -3.7494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3070   -5.2502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6078   -5.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6103   -7.1988    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6003   -1.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8990   -0.7455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2003   -1.4932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4990   -0.7410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2024   -2.6932    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8933    0.7553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9299    1.3599    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -7.8003   -1.4887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.0990   -0.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4003   -1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6994   -0.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.9984   -1.4842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.9984   -2.9842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -11.6994   -3.7342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -10.4004   -2.9843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3383   -1.3500    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    2.7000    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  -14.0377   -3.5842    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  2  7  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 14 18  2  0
 18 19  1  0
 16 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 22 27  1  0
 26 27  2  0
  2 28  1  0
  4 29  1  0
 25 30  1  0
M  END

Associated Targets(Human)

2008 (263 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dync1h1 Dynein heavy chain (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 547.68Molecular Weight (Monoisotopic): 544.9716AlogP: 4.32#Rotatable Bonds: 10
Polar Surface Area: 96.94Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.41CX Basic pKa: 9.95CX LogP: 3.55CX LogD: 2.66
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.18Np Likeness Score: -0.16

References

1. Zhu G, Yang F, Balachandran R, Höök P, Vallee RB, Curran DP, Day BW..  (2006)  Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors.,  49  (6): [PMID:16539395] [10.1021/jm051030l]

Source